What dosing options are available for the olmesartan/hydrochlorothiazide fixed‑dose combinations (Olmesartan HCTZ or Micardis HCT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dosing Options for Olmesartan/HCTZ and Micardis HCT

Olmesartan/HCTZ (Benicar HCT) is available in three fixed-dose combinations: 20/12.5 mg, 40/12.5 mg, and 40/25 mg, while Micardis HCT (telmisartan/HCTZ) is available in 40/12.5 mg, 80/12.5 mg, and 80/25 mg combinations. 1, 2

Olmesartan/HCTZ (Benicar HCT) Dosing

The available fixed-dose combinations are:

  • 20 mg olmesartan/12.5 mg HCTZ
  • 40 mg olmesartan/12.5 mg HCTZ
  • 40 mg olmesartan/25 mg HCTZ

All formulations are dosed once daily 1

Micardis HCT (Telmisartan/HCTZ) Dosing

The available fixed-dose combinations are:

  • 40 mg telmisartan/12.5 mg HCTZ
  • 80 mg telmisartan/12.5 mg HCTZ
  • 80 mg telmisartan/25 mg HCTZ

All formulations are dosed once daily and may be taken with or without food 2

Practical Titration Strategy

Starting approach: Begin with the lower-dose combination (olmesartan 20/12.5 mg or telmisartan 40/12.5 mg) in most patients, particularly those new to combination therapy 2

Titration timeline: Assess blood pressure response after 2-4 weeks. If BP remains uncontrolled, uptitrate to the next strength 2, 3

Maximum doses:

  • Olmesartan/HCTZ: 40/25 mg once daily
  • Telmisartan/HCTZ: 80/25 mg once daily (can be increased to 160/25 mg using two 80/12.5 mg tablets, though this exceeds standard fixed-dose combinations) 2

Special Populations

Renal impairment: Use standard regimens if creatinine clearance >30 mL/min. For CrCl <30 mL/min, loop diuretics are preferred over thiazides, making these combinations inappropriate 2

Hepatic impairment: Not recommended in severe hepatic impairment. In mild-to-moderate hepatic insufficiency or biliary obstruction, initiate with the lowest dose combination (olmesartan 40/12.5 mg or telmisartan 40/12.5 mg) under close supervision 2

Elderly patients (≥65 years): Standard dosing applies. Studies demonstrate safety and efficacy across all age groups, including those ≥80 years, with no increased risk of hypotension-related adverse events 4, 5

Clinical Efficacy Data

Research demonstrates that olmesartan/HCTZ combinations produce substantial BP reductions. The 40/25 mg combination achieves mean reductions of approximately 26.8/21.9 mmHg from baseline, with BP goal rates (<140/90 mmHg) reaching 56-88% depending on baseline severity 3, 6, 4. Adding HCTZ 12.5 mg to olmesartan 40 mg monotherapy provides an additional 3.1 mmHg reduction in diastolic BP compared to monotherapy alone 3.

Related Questions

What is the appropriate starting dose of olmesartan medoxomil combined with hydrochlorothiazide for stage 2 hypertension?
What is the recommended initial dose, titration schedule, monitoring parameters, contraindications, and next‑step management for olmesartan in treating hypertension?
What is the appropriate outpatient management plan for an 80‑year‑old male with hypertension who recently experienced a hypertensive urgency and is currently taking olmesartan 40 mg daily and hydrochlorothiazide 25 mg daily?
A 52-year-old patient on amlodipine, triamterene, and hydrochlorothiazide has persistent blood pressure of 151/102 mm Hg; what is the next step in management?
In a 42-year-old male with hypertension treated with olmesartan who has three days of loss of taste, a dry cough, periumbilical pain, occasional constipation, low‑grade fever, clear lungs, normal heart rate, oxygen saturation, and blood pressure, what is the most likely diagnosis and recommended outpatient treatment?
Which foods are recommended to prevent constipation?
For a hospitalized medical patient with a Padua prediction score ≥ 4, how long should pharmacologic venous thromboembolism prophylaxis be given, and when should it be extended after discharge?
What are the criteria for diagnosing feeding problems in a newborn and the rationale for each criterion?
What are the side effects of hormone replacement therapy in women?
What are the side effects of estradiol?
What does elevated luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) indicate in a male, and what are the appropriate next steps for evaluation and management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.